ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detectin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JACKSON Simon Mark, SHAN Bei, KET Randal Robert, CAO Quiong, PIPER Derek Evan, SHEN Wenyan, CHAN Joyce Chi Yee, WALKER Nigel Pelham Clinton, CARABEO Teresa Arazas, KING Chadwick Terence, MEHLIN Christopher
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JACKSON Simon Mark
SHAN Bei
KET Randal Robert
CAO Quiong
PIPER Derek Evan
SHEN Wenyan
CHAN Joyce Chi Yee
WALKER Nigel Pelham Clinton
CARABEO Teresa Arazas
KING Chadwick Terence
MEHLIN Christopher
description Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI3666797TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI3666797TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI3666797TT13</originalsourceid><addsrcrecordid>eNrjZAh09AvxdHf1U3Dy9HPx9HNXCAjyD3H19AtWCPEHsaFcBWd_vzDXoBDHYFeF4FCnEE8fz2CgqLdrBJAMiQxwVbBU0AhwDva21ORhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHBnsZmZmbmluYhIYbGxKgBAMTPL_U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)</title><source>esp@cenet</source><creator>JACKSON Simon Mark ; SHAN Bei ; KET Randal Robert ; CAO Quiong ; PIPER Derek Evan ; SHEN Wenyan ; CHAN Joyce Chi Yee ; WALKER Nigel Pelham Clinton ; CARABEO Teresa Arazas ; KING Chadwick Terence ; MEHLIN Christopher</creator><creatorcontrib>JACKSON Simon Mark ; SHAN Bei ; KET Randal Robert ; CAO Quiong ; PIPER Derek Evan ; SHEN Wenyan ; CHAN Joyce Chi Yee ; WALKER Nigel Pelham Clinton ; CARABEO Teresa Arazas ; KING Chadwick Terence ; MEHLIN Christopher</creatorcontrib><description>Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.</description><language>eng ; slv</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231030&amp;DB=EPODOC&amp;CC=SI&amp;NR=3666797T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231030&amp;DB=EPODOC&amp;CC=SI&amp;NR=3666797T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JACKSON Simon Mark</creatorcontrib><creatorcontrib>SHAN Bei</creatorcontrib><creatorcontrib>KET Randal Robert</creatorcontrib><creatorcontrib>CAO Quiong</creatorcontrib><creatorcontrib>PIPER Derek Evan</creatorcontrib><creatorcontrib>SHEN Wenyan</creatorcontrib><creatorcontrib>CHAN Joyce Chi Yee</creatorcontrib><creatorcontrib>WALKER Nigel Pelham Clinton</creatorcontrib><creatorcontrib>CARABEO Teresa Arazas</creatorcontrib><creatorcontrib>KING Chadwick Terence</creatorcontrib><creatorcontrib>MEHLIN Christopher</creatorcontrib><title>ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)</title><description>Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAh09AvxdHf1U3Dy9HPx9HNXCAjyD3H19AtWCPEHsaFcBWd_vzDXoBDHYFeF4FCnEE8fz2CgqLdrBJAMiQxwVbBU0AhwDva21ORhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHBnsZmZmbmluYhIYbGxKgBAMTPL_U</recordid><startdate>20231030</startdate><enddate>20231030</enddate><creator>JACKSON Simon Mark</creator><creator>SHAN Bei</creator><creator>KET Randal Robert</creator><creator>CAO Quiong</creator><creator>PIPER Derek Evan</creator><creator>SHEN Wenyan</creator><creator>CHAN Joyce Chi Yee</creator><creator>WALKER Nigel Pelham Clinton</creator><creator>CARABEO Teresa Arazas</creator><creator>KING Chadwick Terence</creator><creator>MEHLIN Christopher</creator><scope>EVB</scope></search><sort><creationdate>20231030</creationdate><title>ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)</title><author>JACKSON Simon Mark ; SHAN Bei ; KET Randal Robert ; CAO Quiong ; PIPER Derek Evan ; SHEN Wenyan ; CHAN Joyce Chi Yee ; WALKER Nigel Pelham Clinton ; CARABEO Teresa Arazas ; KING Chadwick Terence ; MEHLIN Christopher</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI3666797TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JACKSON Simon Mark</creatorcontrib><creatorcontrib>SHAN Bei</creatorcontrib><creatorcontrib>KET Randal Robert</creatorcontrib><creatorcontrib>CAO Quiong</creatorcontrib><creatorcontrib>PIPER Derek Evan</creatorcontrib><creatorcontrib>SHEN Wenyan</creatorcontrib><creatorcontrib>CHAN Joyce Chi Yee</creatorcontrib><creatorcontrib>WALKER Nigel Pelham Clinton</creatorcontrib><creatorcontrib>CARABEO Teresa Arazas</creatorcontrib><creatorcontrib>KING Chadwick Terence</creatorcontrib><creatorcontrib>MEHLIN Christopher</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JACKSON Simon Mark</au><au>SHAN Bei</au><au>KET Randal Robert</au><au>CAO Quiong</au><au>PIPER Derek Evan</au><au>SHEN Wenyan</au><au>CHAN Joyce Chi Yee</au><au>WALKER Nigel Pelham Clinton</au><au>CARABEO Teresa Arazas</au><au>KING Chadwick Terence</au><au>MEHLIN Christopher</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)</title><date>2023-10-30</date><risdate>2023</risdate><abstract>Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slv
recordid cdi_epo_espacenet_SI3666797TT1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A18%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JACKSON%20Simon%20Mark&rft.date=2023-10-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI3666797TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true